Register

Forgot your password?

Forgot your username?

GlySure

Units 4-6 The Quadrant, Abingdon Science Park
Abingdon, Oxfordshire OX14 3YS United Kingdom
phone:phone
fax:fax
Click for website
Research Sector Medical Devices
Summary Description Developed a continuous intravascular glucose sensor for use in the ICU market to enable implementation of Tight Glycemic Control (TGC) protocols

Click here for Financial Data Keywordsglucose monitoring, intravascular, optical fluorescence-based sensor, tight glycemic control, insulin therapy, diabetes, obesity

Description

Glysure has developed a continuous intravascular glucose sensor for use in the ICU market to enable implementation of Tight Glycemic Control (TGC) protocols, a market estimated at >$2Bn. TGC is the r......view more

Products / Services

The GlySure System comprises two main parts, a monitor and a sterile sensor set which includes an integrated fiber-optic sensor/introducer and a fully automated calibration module. The sensor inter......view more


Technology / Differentiation

The core to this technology is the fluorescent/receptor glucose indicator chemistry. This chemistry is structured to be selective for glucose and is immobilised into an optical cell that is micro mach...view more

Market / Customers

Infrequent glucose monitoring could be putting patient lives at risk. At present, clinicians do not have an easy, accurate and affordable technology to allow the frequent glucose monitoring required f......view more


Strategy

Since the NEJM paper, and over the past ten years, the practice of TGC and Intensive Insulin Therapy (IIT) has been widely adopted in hospitals worldwide. However, most hospitals will admit that TG...view more

Analyst Coverage

GlySure has been covered in IN VIVO, Start-UP, MD&DI, The Gray Sheet, The Engineer and others. For a complete list of news coverage visit www.glysure.com...view more